Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears INDs for Surface Oncology's antibody candidates SRF-617 and SRF-388

Jan. 28, 2020

Sichuan Kelun-Biotech Biopharmaceutical discloses RORC agonists

Jan. 28, 2020

PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint

Jan. 28, 2020

miR-3064-5p found to have prognostic value in HCC

Jan. 28, 2020

FDA approves Trijardy XR for type 2 diabetes

Jan. 28, 2020

GeoVax and BravoVax sign letter of intent to codevelop 2019-nCoV coronavirus vaccine

Jan. 28, 2020

New CRLF2 ligands identified at Korea University Research and Business Foundation

Jan. 28, 2020

Novartis Inflammasome Research describes new NLRP3 inflammasome inhibitors

Jan. 28, 2020

Gilead describes new IDO-1 inhibitors

Jan. 28, 2020

New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech

Jan. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.